Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

NCT02899962 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02899962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02899962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2017
Completion date
June 26, 2019
Enrollment
722 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris